Stock MarketROI
Closed
VEEV

VEEV

Healthcare · Health Information Services

$162.17+1.65%
Mkt Cap: $26.34B

Performance

VEEV (VEEV) Stock Analysis 2026

Rule-based · Updated daily · Not financial advice

VEEV (VEEV) operates in the Health Information Services space within the Healthcare sector. With a market cap of $26.3B, it qualifies as a mid-cap company. The company is growing revenue strongly while maintaining healthy profitability — a combination that investors typically reward with a premium valuation.

Bull Case5
  • Forward P/E (16.2×) is lower than trailing P/E (28.8×) — analysts expect earnings to improve
  • Revenue growth of 16% YoY shows solid business momentum
  • Exceptional profit margin of 28.4% — the business retains a large share of each dollar earned
  • Current ratio of 4.7× — ample short-term liquidity
  • Price is near its 52-week low — potential entry point with asymmetric upside
Bear Case2
  • P/E of 28.8× is above average — valuation requires continued strong growth to justify
  • No dividend history — total return depends entirely on price appreciation

Verdict

Strong Buy

Multiple fundamental strengths with few red flags. Long-term buyers may find this compelling.

AI Insight

Powered by Claude

AI-generated analysis for informational purposes only. Not financial advice.

Related Articles

Revenue & Results

Dividends

This stock does not pay dividends.

If You Had Invested…

Hypothetical return based on historical prices

$

* Dividend reinvestment calculated at ex-date price. For informational purposes only.

Earnings

Next Earnings

Sep 2, 2026

78

days

EPS (TTM)

$5.64

P/E (TTM)

28.8

Fwd P/E

16.2

Earnings History

SEC EDGAR · official filings

SEC filings

SEC Filings

Official EDGAR documents

All filings

Key Statistics

Valuation

Market Cap$26.34B
P/E Ratio28.75
Forward P/E16.16
P/B Ratio
PEG Ratio0.72
EPS (TTM)$5.64

Trading

Open
Day High
Day Low
52W High$310.50
52W Low$148.05
Volume
Avg Volume (3M)3,005,795
Beta0.95

Dividends

Dividend Yield
Annual Rate
Ex-Div Date
Payout Ratio0.00%

Profitability

Profit Margin28.37%
Operating Margin30.93%
ROE13.93%
ROA7.30%
Revenue Growth16.30%
Earnings Growth14.60%

Balance Sheet

Total Revenue$3.32B
Total Debt$103.07M
Debt / Equity1.41
Current Ratio4.74
Free Cash Flow$1.26B

Fair Value Estimates

Current price: $162.17

Graham Number

√(22.5 × EPS × Book Value)

$74.77

-53.9% downside

Benjamin Graham's intrinsic value formula. Assumes a fair stock trades at no more than 22.5× the product of EPS and book value per share.

Bazin Ceiling Price

Avg. Annual DPS (5Y) ÷ 6%

N/A

Décio Bazin's dividend-based ceiling. The max price you should pay so that dividends alone deliver at least 6% annual yield on your cost basis.

These are simplified estimates. Not financial advice.

Buy & Hold Checklist

Quality criteria for long-term holding

7/10

88% score

Pays dividends

No dividend history found

Dividend consistency (5Y+)

Uninterrupted dividend payments for at least 5 years

ROE above 10%

13.9%

Return on equity — measures how efficiently capital is used

Positive profit margin

28.4%

Net profit margin must be positive — company earns more than it spends

Revenue growth (annual)

+16.3%

Annual revenue must be growing compared to the prior year

Earnings growth (annual)

+14.6%

Annual earnings must be growing compared to the prior year

Debt/Equity below 2×

1.41×

Low financial leverage reduces risk of distress

Current ratio above 1

4.74×

Short-term assets must cover short-term liabilities

Daily liquidity above $5M

$487M/day

High trading volume ensures easy entry and exit

Dividend yield above 0%

Stock must distribute income to shareholders

Related Assets

Healthcare

About VEEV

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

Sector

Healthcare

Industry

Health Information Services

Location

Pleasanton, United States

Employees

7,928